A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes

NCT04955834 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

344

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Insulin degludec injection
DRUG: Tresiba®

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.